CLINICAL TRIALS AND OBSERVATIONS Long-term study of indolent adult T-cell leukemia-lymphoma
نویسندگان
چکیده
1Third Department of Internal Medicine, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki; 2Department of Molecular Medicine and Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki; 3Department of Nutritional Health, Faculty of Wellness Studies, Kwassui Women’s College, Nagasaki; 4Division of Cytokine Signaling, Department of Molecular Microbiology and Immunology and 5Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki; and 6Department of Hematology, Hirado Municipal Hospital, Nagasaki, Japan
منابع مشابه
CLINICAL TRIALS AND OBSERVATIONS Upfront immunization with autologous recombinant idiotype Fab fragment without prior cytoreduction in indolent B-cell lymphoma
Idiotype vaccination for follicular lymphoma is primarily being developed as remission consolidation after chemotherapy. We investigated idiotype vaccination as primary intervention for treatmentnaive indolent B-cell lymphoma and in a separate cohort as remission consolidation after chemotherapy to assess immunization-induced immune responses in relation to progression-free survival (German Cli...
متن کاملCLINICAL TRIALS AND OBSERVATIONS Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation
Although mycosis fungoides (MF) is typically an indolent disease, patients with advanced-stage disease (stages IIB-IVB), including Sézary syndrome (SS), often have a poor outcome. A 31-year, retrospective analysis of our cutaneous lymphoma database, of 297 patients with MF and SS, was undertaken to study longterm outcomes and identify clinical predictors of outcome in patients with advanced-sta...
متن کاملCLINICAL TRIALS AND OBSERVATIONS UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia
Patel, Elisabeth Paietta, Martin S. Tallman and Anthony H. Goldstone Hillard Lazarus, Selina M. Luger, David I. Marks, Andrew K. McMillan, Anthony V. Moorman, Bella Adele K. Fielding, Jacob M. Rowe, Georgina Buck, Letizia Foroni, Gareth Gerrard, Mark R. Litzow, lymphoblastic leukemia regimen enhances long-term outcomes in Philadelphia positive acute UKALLXII/ECOG2993: addition of imatinib to a ...
متن کاملCLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis
The BCR-ABL fusion, the molecular equivalent of the Philadelphia translocation, gains importance for treatment stratification in adult acute lymphoblastic leukemia (ALL). In this prospective study, samples from 478 patients with CD101 B-cell precursor ALL (c-ALL and pre-B ALL) underwent BCR-ABLreversetranscription–polymerase chain reaction (RT-PCR) analysis with double testing of positive sampl...
متن کاملCLINICAL TRIALS AND OBSERVATIONS Radioimmunotherapy of relapsed indolent non-Hodgkin lymphoma with 131I-rituximab in routine clinical practice: 10-year single-institution experience of 142 consecutive patients
Radioimmunotherapy of indolent nonHodgkin lymphoma (NHL) has achieved objective response rates in clinical trials comparable with standard rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy, but is relatively underused in routine practice. In this article, we report our clinical experience in 142 consecutive patients who received iodine-131 rituximab radioimm...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2010